GR3033772T3 - Mycobacterium vaccae for treatment of long term autoimmune conditions - Google Patents

Mycobacterium vaccae for treatment of long term autoimmune conditions

Info

Publication number
GR3033772T3
GR3033772T3 GR20000401468T GR20000401468T GR3033772T3 GR 3033772 T3 GR3033772 T3 GR 3033772T3 GR 20000401468 T GR20000401468 T GR 20000401468T GR 20000401468 T GR20000401468 T GR 20000401468T GR 3033772 T3 GR3033772 T3 GR 3033772T3
Authority
GR
Greece
Prior art keywords
treatment
long term
mycobacterium vaccae
autoimmune conditions
term autoimmune
Prior art date
Application number
GR20000401468T
Other languages
English (en)
Inventor
John Lawson Stanford
Graham Arthur William Rook
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London filed Critical Univ London
Publication of GR3033772T3 publication Critical patent/GR3033772T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Storage Of Fruits Or Vegetables (AREA)
  • External Artificial Organs (AREA)
  • Soil Working Implements (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR20000401468T 1992-02-21 2000-06-23 Mycobacterium vaccae for treatment of long term autoimmune conditions GR3033772T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929203814A GB9203814D0 (en) 1992-02-21 1992-02-21 Treatment of long term auto-immune conditions
EP93905460A EP0630259B1 (en) 1992-02-21 1993-02-19 Mycobacterium vaccae for treatment of long term autoimmune conditions

Publications (1)

Publication Number Publication Date
GR3033772T3 true GR3033772T3 (en) 2000-10-31

Family

ID=10710862

Family Applications (2)

Application Number Title Priority Date Filing Date
GR970401763T GR3024113T3 (en) 1992-02-21 1997-07-16 Mycobacterium vaccae for treatment of long term autoimmune conditions.
GR20000401468T GR3033772T3 (en) 1992-02-21 2000-06-23 Mycobacterium vaccae for treatment of long term autoimmune conditions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GR970401763T GR3024113T3 (en) 1992-02-21 1997-07-16 Mycobacterium vaccae for treatment of long term autoimmune conditions.

Country Status (24)

Country Link
US (1) US5885588A (el)
EP (2) EP0763361B1 (el)
JP (1) JPH07506093A (el)
KR (1) KR100275862B1 (el)
AT (2) ATE151641T1 (el)
AU (2) AU675421B2 (el)
BG (1) BG99054A (el)
BR (1) BR9305946A (el)
CA (1) CA2130117A1 (el)
CZ (1) CZ282651B6 (el)
DE (2) DE69328503T2 (el)
DK (2) DK0630259T3 (el)
ES (2) ES2104131T3 (el)
FI (1) FI943849A0 (el)
GB (1) GB9203814D0 (el)
GR (2) GR3024113T3 (el)
HU (1) HU218347B (el)
NO (1) NO311169B1 (el)
NZ (1) NZ249518A (el)
RO (1) RO117833B1 (el)
RU (1) RU2124367C1 (el)
SK (1) SK99994A3 (el)
UA (1) UA35583C2 (el)
WO (1) WO1993016727A1 (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9406301D0 (en) * 1994-03-30 1994-05-25 Univ London Immunotherapeutic agent and its use
IL110011A (en) * 1994-06-13 2004-09-27 Yeda Res & Dev Pharmacological preparations for the treatment of schizophrenia
GB9505658D0 (en) * 1995-03-21 1995-05-10 Univ London Hormone and growth factor mimetics
US6056964A (en) * 1995-03-29 2000-05-02 Stanford Rook Limited Immunotherapeutic agent and its use
AU741016B2 (en) * 1996-08-29 2001-11-22 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6160093A (en) * 1996-08-29 2000-12-12 Genesis Researth And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
AU730548B2 (en) * 1996-12-18 2001-03-08 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the TH2 activity of the immune system
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
RU2137137C1 (ru) * 1997-12-03 1999-09-10 Научно-исследовательский институт по изучению лепры Способ определения m.leprae у больных с регрессом заболевания
EP1044273A2 (en) * 1997-12-23 2000-10-18 Genesis Research & Development Corporation Limited COMPOSITIONS DERIVED FROM $i(MYCOBACTERIUM VACCAE) AND METHODS FOR THEIR USE
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
WO2001010221A1 (en) * 1999-08-06 2001-02-15 Corixa Corporation Vaccines for the treatment of autoimmune disease
GB0010496D0 (en) * 2000-04-28 2000-06-14 Stanford Rook Ltd Treatment of conditions of the central nervous system
GB0106986D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeutic agent
GB0106985D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeutic agent
WO2005049056A2 (en) * 2003-11-14 2005-06-02 Ucl Biomedica Plc Immune modulator comprising whole cell rhodococcus, gordonia, nocardia, dietzia, tsukamurella or nocardioides bacteria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
CA2095855C (en) * 1990-11-08 2003-04-29 Graham A.W. Rook Mycobacterium as adjuvant for antigens

Also Published As

Publication number Publication date
NZ249518A (en) 1997-07-27
DE69328503T2 (de) 2000-08-24
DE69328503D1 (de) 2000-05-31
FI943849A0 (fi) 1994-08-22
AU7188796A (en) 1997-02-06
KR100275862B1 (ko) 2000-12-15
EP0630259B1 (en) 1997-04-16
AU3637793A (en) 1993-09-13
CZ282651B6 (cs) 1997-08-13
NO943082L (no) 1994-10-17
EP0763361A2 (en) 1997-03-19
WO1993016727A1 (en) 1993-09-02
RO117833B1 (ro) 2002-08-30
DK0630259T3 (da) 1997-09-15
ATE151641T1 (de) 1997-05-15
BR9305946A (pt) 1997-10-21
HUT69941A (en) 1995-09-28
AU675421B2 (en) 1997-02-06
HU9402422D0 (en) 1994-10-28
GR3024113T3 (en) 1997-10-31
US5885588A (en) 1999-03-23
EP0630259A1 (en) 1994-12-28
NO311169B1 (no) 2001-10-22
BG99054A (en) 1995-08-28
DE69309915D1 (de) 1997-05-22
CZ202394A3 (en) 1995-02-15
RU2124367C1 (ru) 1999-01-10
HU218347B (hu) 2000-08-28
GB9203814D0 (en) 1992-04-08
SK99994A3 (en) 1995-05-10
AU706122B2 (en) 1999-06-10
ES2104131T3 (es) 1997-10-01
RU94045825A (ru) 1997-02-20
DK0763361T3 (da) 2000-08-07
EP0763361A3 (en) 1997-03-26
EP0763361B1 (en) 2000-04-26
UA35583C2 (uk) 2001-04-16
DE69309915T2 (de) 1997-07-24
ATE192046T1 (de) 2000-05-15
CA2130117A1 (en) 1993-09-02
NO943082D0 (no) 1994-08-22
KR950700755A (ko) 1995-02-20
JPH07506093A (ja) 1995-07-06
ES2145968T3 (es) 2000-07-16

Similar Documents

Publication Publication Date Title
HUT69941A (en) Material derived from mycobacterium vaccae for treatment of long term autoimmune conditions
GR3018652T3 (en) Mycobacterium vaccae in the treatment of uveitis
AU7783587A (en) Novel osteoinductive compositions
EG19730A (en) Method of preparing and use of magnesium-pyridoxal-5-phosphate-glutaminate for the prevention of diseases which result from vascular lesions
CA2064029A1 (en) Use of mycobacterium vaccae in the prevention of aids
AU6110490A (en) 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular diseases
ZA929316B (en) Method of preventing reocclusion of arteries
DE3884241D1 (de) Analoge des Porcin-Wachstumshormones.
EP0789031A3 (el)
Willatts Addition to the Catalogue of Early Iron Graveslabs in the Weald1

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees